By Associate Professor Laurence P. G. Wakelin

Book Chapters

Wolf S; Wakelin L; Catchpoole DR, 2011, 'Considerations for Treatment Development in Rhabdomyosarcoma: In Vitro Assessment of Novel DNA Binding Drugs', in Derbel F (ed.), Soft Tissue Tumors, InTech, November, 2011, pp. 3 - 30

Wickham G; Wakelin L; Palmer B; Lee H; Johnson P; Baguley BC; Denny WA; McFadyen DW, 1991, 'Cis-diammine platinum (II) complexes tethered to DNA-affinic ligands: antitumour activity and DNA-binding properties', in Howell SB (ed.), Proceedings of the Sixth International Symposium on Platinum and Other Metal Co-ordination Compounds in Cancer Chemotherapy, Plenum, New York, pp. 51 - 60

Wakelin L, 1991, 'On creating targets in DNA designed to be 'hot-spots' for radiation damage.', in Seymour C; Mothersill C (ed.), New Developments in Fundamental and Applied Radiobiology, Taylor and Francis, London, pp. 269 - 274

Wakelin L; Waring M, 1990, 'DNA intercalating agents', in Hansch C; Sammes PG; Taylor JB (ed.), Comprehensive Medicinal Chemistry, The Rational Design, Mechanistic Study, and Therapeutic Application of Chemical Compounds, Pergamon Press, Oxford, UK, pp. 703 - 724

Wakelin L; Denny WA, 1990, 'Kinetic and equilibrium binding studies of a series of intercalating agents that bind by threading a sidechain through the DNA helix', in Pullman B; Jortner J (ed.), Molecular Basis of Specificity in Nucleic Acid-Drug Interactions, Kluwer Academic Publishers, Dordrecht, pp. 191 - 206

Denny WA; Wakelin L, 1988, 'Tricyclic carboxamides: relationships between antitumour activity and geometry and kinetics of binding to DNA.', in Sarma RH; Sarma MH (ed.), Structure and Expression: DNA and Its Drug Complexes, Adenine Press, USA, pp. 329 - 337

Back to profile page